Germany helping Taiwan on BioNTech vaccine deal | Inquirer News

Germany helping Taiwan on BioNTech vaccine deal

/ 03:17 PM June 02, 2021
Germany helping Taiwan on BioNTech vaccine deal

FILE PHOTO: A syringe with the Pfizer-BioNTech COVID-19 vaccine is prepared at a coronavirus disease (COVID-19) vaccination center in Naples, Italy, January 8, 2021. REUTERS/Ciro De Luca/File Photo

TAIPEI Germany’s top diplomat in Taipei said his government has been helping in talks between Taiwan and drugmaker BioNTech SE to supply COVID-19 vaccines, after Taiwan said a deal fell apart earlier this year due to Chinese “intervention”.

China denied that accusation. But a war of words escalated after the Chinese-claimed island of Taiwan rejected Beijing’s offer to supply it with shots made by Shanghai Fosun Pharmaceutical Group Co Ltd, which holds a contract to sell them in Greater China.


In a Facebook post in Chinese on Wednesday, Thomas Prinz, Germany’s de facto ambassador to Taiwan, said they had “noticed the recent controversy regarding vaccine acquisition.”

“Please believe that the German government, especially Federal Economy Minister Altmaier himself, have made great efforts in the continuous communication and coordination between Taiwan and BioNTech,” he said, adding that whether a contract is eventually signed would depend on the two parties.


“If the parties to the contract can reach a consensus, the federal government is naturally happy to see it happen.”

Germany’s BioNTech asked Taiwan to remove the word “country” from their planned joint announcement on a COVID-19 vaccine sale to the island, its health minister said last week.

Prinz noted Germany’s donations to the COVAX global vaccine sharing scheme for lower-income countries, through which Taiwan has already received AstraZeneca Plc shots.

“I hope that there will be enough vaccines from different brands, including BioNTech, imported into Taiwan as soon as possible.”

Taiwan Health Minister Chen Shih-chung, speaking at his daily news conference, expressed thanks to Germany for “giving us a lot of assistance” in efforts to buy the BioNTech vaccine.

Neither BioNTech or Fosun immediately responded to a request for comment.

Germany, like most countries, has no formal diplomatic ties with Taiwan and only recognizes the government in Beijing.


Altmaier wrote to his opposite number in Taiwan in January to ask for help persuading manufacturers in Taiwan, home to the world’s largest contract chipmaker and one of Germany’s main suppliers, Taiwan Semiconductor Manufacturing Co Ltd (TSMC), to ease a global shortage of chips.

Taiwan responded by saying it was asking for Germany’s help in securing COVID-19 vaccines.

While Taiwan’s government says it has not totally given up on obtaining BioNTech shots, Foxconn and its billionaire founder Terry Gou sought permission from Taiwan’s government on Tuesday to buy the vaccines from the firm.

Taiwan has vaccinated only around 3% of its 23.5 million people, but has millions of shots on order.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: BioNTech, COVID-19, Germany, Health, Taiwan, vaccine, Virus
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.